Consensus Cloud Solutions (CCSI) Q2 2026 earnings review
Corporate Momentum Surges as SoHo Finally Stabilizes
Consensus delivered a surprisingly strong Q2, breaking the $90 million revenue mark for the first time in recent quarters. Total revenue grew 4.1% YoY, driven by an accelerating Corporate segment that jumped 9.3% to $60.5 million. Crucially, the legacy SoHo business—which had been a massive drag on growth—stabilized significantly, shrinking just 4.7% YoY compared to near-10% declines in previous quarters. While reported Net Income surged 32%, this was heavily inflated by a $5.3 million unrealized investment gain. Adjusted EBITDA remained flat YoY at $48.3 million, as management successfully executed on previously promised hiring investments, compressing margins to 52.9%. The board doubled the share buyback authorization to $200 million, signaling strong internal confidence despite management conservatively maintaining flat full-year guidance.
🐂 Bull Case
The pivot to enterprise and healthcare is working. The Corporate segment grew 9.3% YoY, marking its fastest growth rate since Q4 2022, proving high demand for secure, compliance-driven digital workflows.
The company doubled its share repurchase authorization to $200 million. Backed by a highly cash-generative model ($25.5 million FCF in Q2), Consensus is aggressively reducing its share count.
🐻 Bear Case
Adjusted EBITDA margins contracted from 54.8% a year ago to 52.9%. Growth is requiring heavier investments in personnel and go-to-market strategies, limiting flow-through to the bottom line.
While GAAP Net Income looked spectacular (+32%), it was artificially boosted by a $5.3 million unrealized gain on investments. True operational adjusted net income was practically flat (+0.7% YoY).
⚖️ Verdict: 🟢
Bullish. The long-awaited stabilization of the SoHo segment, combined with accelerating momentum in the Corporate channel, proves the turnaround strategy is working. The expanded buyback adds a highly attractive capital return pillar.
Key Themes
Corporate Channel Engine Reaches New Gear
Accelerating. The Corporate channel continues to be the central pillar of the growth story. Revenue hit $60.5 million, with YoY growth accelerating sequentially to 9.3%. Corporate customer accounts grew 9.8% YoY to 67,000, and ARPA held steady at $304.86. This validates the success of shifting focus toward large healthcare and public sector accounts.
SoHo Channel Halts the Bleeding
Reversing. For multiple quarters, the legacy SoHo business was a predictable dead weight, declining roughly 10% YoY. In Q2, SoHo performed significantly better than management expected, shrinking just 4.7% YoY. More importantly, it actually grew sequentially from $29.7 million in Q1 to $30.9 million in Q2. If SoHo has found a floor, consolidated revenue growth will accelerate much faster.
Margin Normalization via Planned Hiring
Decelerating. Adjusted EBITDA margins dropped to 52.9% from 54.8% a year ago and 54.1% in Q1. While this was explicitly telegraphed by management in Q1 as a necessary 'catch-up' in go-to-market and engineering hiring, it confirms that sustained top-line growth requires heavy operational investments, capping near-term profitability.
Aggressive Capital Deployment
Stable. Consensus continues to leverage its massive cash flow. The board increased the total share repurchase authorization to $200 million. During Q2, they repurchased roughly 300,000 shares for $9.6 million, taking advantage of what management called 'attractive prices.' With $98.9 million in cash on the balance sheet, expect this aggressive pace to continue.
AI Monetization through eFax Clarity
Management continues to evolve the platform from a simple transport layer to an 'intelligence layer.' Though not explicitly quantified in the Q2 release, previous commentary highlighted AI-driven tools like eFax Clarity as key to solving labor shortages in healthcare administration, helping to maintain high Corporate retention and secure higher-tier deal conversions.
Other KPIs
Accelerating. Free cash flow grew 25.1% YoY from $20.3 million, driven by strong operating income conversions and well-managed capital expenditures ($7.8 million). This robust cash generation is the engine funding both debt repurchases and the newly expanded $200 million share buyback program.
Stable. While GAAP Net Income showed a massive 31.7% increase, Adjusted Net Income paints the true operational picture. After stripping out a $5.3 million unrealized gain on investments and share-based compensation, adjusted net income was flat YoY (+0.7%), entirely aligned with the flat Adjusted EBITDA.
Guidance
Stable. The $91.2 million midpoint represents essentially flat sequential growth compared to Q2's $91.4 million, but implies a solid ~3.8% YoY growth compared to Q3 2025.
Decelerating implied back-half. Management reaffirmed the $357 million midpoint. However, with H1 revenue already at $179.8 million, achieving the midpoint requires only $177.2 million in H2. This implies an overly conservative sequential deceleration that contradicts the strong Q2 momentum.
Stable. Reaffirmed at a $187.5 million midpoint. Given H1 Adjusted EBITDA was $96.2 million, the implied H2 EBITDA is $91.3 million. This reflects management's commitment to continued operational hiring and G&A expansion throughout the rest of the year, which will keep margins compressed.
Key Questions
SoHo Channel Floor
The SoHo segment delivered an unexpected sequential revenue increase and a significantly softer YoY decline. Is this driven by a one-time pricing adjustment/retention event, or has the segment genuinely found a sustainable revenue floor?
Guidance Conservatism
First-half revenue totaled nearly $180 million. Reaffirming the $357 million full-year midpoint implies a second-half revenue slowdown. Are there specific macro or seasonal headwinds anticipated, or is this simply a 'philosophical' adherence to maintaining guidance?
AI Product Conversions
How much of the 9.3% growth in the Corporate segment can be directly attributed to the rollout of the re-architected eFax platform and AI capabilities like eFax Clarity, versus standard volume expansion from existing healthcare clients?